A Phase 1 interventional study of ketoprofen and ketoprofen in Knee Osteoarthritis, sponsored by New Valley University. Active, not recruiting at 1 site in Egypt. Open to participants aged 45 Years and older. Per ClinicalTrials.gov, last updated 2026-01-06.
Sponsored by New Valley University · Phase 1, Interventional, and Treatment
A single blind randomized controlled clinical study
A single blind randomized controlled clinical study
3,302 studies on the registry are indexed under Osteoarthritis, Knee; 608 are open to participants now.
This study's enrollment of 40 is below the median of 70 across 2,731 interventional studies indexed under Osteoarthritis, Knee.
Browse Osteoarthritis, Knee studies →New Valley University is the lead sponsor of 23 studies on the registry; 12 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Full history taking Physical examination including (joint tenderness, swelling, crepitus and limitation of motion).
Exclusion Criteria:
new formulation of ketoprofen
Drug: ketoprofen
positive control receiving commercial product
Drug: ketoprofen
new gel formulation
commercial gel
Visual Analogue Scale (VAS)
Time frame: 2 weeks
McMaster Universities Arthritis Index (WOMAC)
Time frame: 2 weeks
Plan to share: No
This study is active, not recruiting, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
New Valley University